Aeterna Zentaris Files Management Information Circular
April 09 2018 - 7:00AM
Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) is
pleased to announce that it has filed its Management Information
Circular for the upcoming Annual and Special Meeting of
Shareholders. The Meeting will be held at the offices of Stikeman
Elliott LLP, located on the 41st floor at 1155
René-Lévesque Blvd. West, Montreal, Quebec, Canada, H3B
3V2 on Tuesday, May 8, 2018, at 10:00 a.m. (Eastern
Time). Shareholders will receive the audited consolidated
financial statements of the Corporation for the year ended December
31, 2017, together with the auditors’ report thereon and be asked
to elect directors; to appoint auditors and to authorize the
directors to determine their compensation; and to consider the
ordinary resolution to approve the long-term incentive plan of the
Corporation. The Management Information Circular is available on
www.sedar.com, www.sec.gov and on the Company website
www.aezsinc.com.
The Company encourages shareholders to read the
Management Information Circular in detail. Shareholders who have
questions or have not received their proxy or voting instruction
form may contact Aeterna Zentaris’ Proxy Solicitation Agent:
|
|
|
Laurel Hill Advisory
Group |
|
|
|
Toll free:
1-877-452-7184 or 416-304-0211 |
|
|
|
Email:
assistance@laurelhill.com |
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a specialty
biopharmaceutical company focused on developing and
commercializing, principally through out-licensing arrangements,
Macrilen™ (macimorelin), an orally available ghrelin agonist, to be
used in the diagnosis of patients with adult growth hormone
deficiency. Aeterna Zentaris has entered into a license and
assignment agreement with a wholly-owned subsidiary of Strongbridge
Biopharma plc to carry out development, manufacturing, registration
and commercialization of Macrilen™ (macimorelin) in the United
States and Canada. For more information, visit
www.aezsinc.com.
Contacts:
Aeterna Zentaris Inc. James Clavijo Chief Financial Officer
IR@aezsinc.com 843-900-3201
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From Apr 2023 to Apr 2024